🇺🇸 FDA
Patent

US 8410054

Methods for treating pain by inhibition of the SCN9A channel

granted A61PA61P25/00A61P25/04

Quick answer

US patent 8410054 (Methods for treating pain by inhibition of the SCN9A channel) held by Xenon Pharmaceuticals Inc. expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P25/00, A61P25/04, A61P25/08, A61P29/00